Tanzania's Health Sector at a Pivotal Crossroads

The Fourth Five-Year Development Plan (FYDP IV) 2026/27–2030/31, themed "Reforms for Inclusive Economic Growth and Employment Creation," positions Tanzania on a trajectory toward upper-middle-income status by 2050 under the Dira 2050 long-term vision. As the first operational milestone under Dira 2050, FYDP IV recognises health and social protection as foundational pillars of human capital development, economic productivity, and national resilience.

Tanzania's health sector has recorded commendable progress over the past two decades. Life expectancy increased from 66 years in 2019/20 to an estimated 68.3 years in 2025, while under-five mortality declined sharply from 112 to 43 per 1,000 live births. Maternal mortality fell to 235 per 100,000 live births and stunting among children under five dropped from 48 percent in 1999 to 30 percent in 2022. The number of health facilities expanded to 8,881 nationwide, and public health expenditure reached 11.6 percent of Government expenditure.

Yet significant structural constraints persist. Geographic disparities leave rural and remote communities facing shortages of skilled health workers, limited medicines, and inadequate diagnostic capacity. Health insurance coverage stands at only 15.3 percent (2022), leaving the majority of households vulnerable to financial shocks. The growing burden of non-communicable diseases (NCDs), repeated disease outbreaks, and climate-related health risks further strain the system.

FYDP IV Health KPIs: Baseline vs. 2030/31 Targets

The following key performance indicators define Tanzania's measurable health transformation agenda under FYDP IV, benchmarked from NBS/PHC data and the FYDP III Evaluation Report.

Progress Toward 2031 Targets — Visual Tracker

The 68:24:8 Financing Model — TZS 33.55 Trillion Framework

The health sector financing architecture under FYDP IV is one of the most ambitious public-private partnership models in Tanzania's development planning history. The 68:24:8 private-to-public ratio reflects a market-driven approach that positions the private sector as the principal engine of health investment. The Government will establish a project-risk financing facility to unlock a pipeline of bankable health projects, with PPPC playing the coordinating role.

Health Economy Data — Charts & Trends

Key Issues for Health Sector Transformation Under FYDP IV

FYDP IV identifies six priority thematic areas, each recognised as a binding constraint to health sector transformation. These form the core agenda for public-private dialogue under the PPP Centre's coordination framework.

Bankable PPP Opportunities in Tanzania's Health Sector

FYDP IV positions Public-Private Partnerships as the primary vehicle for health sector transformation. The PPP Centre (PPPC), operating as Tanzania's central PPP coordination agency, aims to identify and structure 5–8 bankable health PPP projects for investor matching by 2027. These opportunities span the full continuum of care and health system functions.

Multi-Stakeholder Architecture for Health PPPs

Effective delivery of FYDP IV's health targets requires coordinated engagement across a broad multi-stakeholder ecosystem spanning government, health service providers, private sector actors, development partners, and civil society.

Measurable Deliverables from FYDP IV Health PPP Strategy

The PPP-driven health transformation agenda under FYDP IV is expected to generate six concrete, time-bound outcomes spanning investment pipeline development, policy reform, digital health pilots, and health coverage expansion.

• 1A pipeline of 5–8 bankable health PPP projects identified and matched with investors by 2027, spanning hospital infrastructure, pharmaceutical manufacturing, health technology, and insurance expansion.
• 2Policy recommendations to strengthen PPP frameworks and align private sector participation with FYDP IV health targets, the UHC agenda, and the malaria-free 2028 milestone.
• 3A financing roadmap articulating roles of government, PSCs, the private sector, and development partners in achieving TZS 33.55 trillion in sectoral investment.
• 4Partnerships for pilot initiatives in digital health systems, mHealth platforms, telemedicine, and community health worker capacity programmes.
• 5A roadmap for achieving 35% health insurance coverage by 2031, including flexible CBHI structures, digital enrolment platforms, and LGA-led outreach programmes.
• 6An agreed monitoring framework aligned to FYDP IV health KPIs covering infant/maternal mortality, life expectancy, UHC enrolment, NCD incidence, and health facility digitalisation.

The Health Economy: Investment, Productivity & National Development

Tanzania's health economy extends far beyond the direct provision of medical services. Under FYDP IV, health investments are explicitly framed as drivers of economic productivity, human capital formation, and national competitiveness. The nexus between health investment and economic growth is central to the Dira 2050 vision of upper-middle-income status.

Human Capital & Labour Productivity

Reductions in infant, maternal, and under-five mortality directly expand Tanzania's productive labour force. Every unit decrease in under-five mortality translates into a larger working-age population over the following two decades. Improvements in life expectancy from 68.3 to 70.4 years extend productive working lives, contributing to GDP growth through sustained labour supply. The World Bank's Human Capital Index framework positions Tanzania's health outcomes as a direct determinant of its economic competitiveness.

Disease Burden Cost Avoidance

The economic case for the malaria-free 2028 campaign alone is compelling: achieving malaria-free status would avoid TZS 4.2 trillion in recurring disease management costs. These fiscal savings can be reallocated toward system strengthening, capital investment in specialised care, or social protection programmes. Similarly, reducing the HIV, TB, and malaria prevalence burden by 30% reduces absenteeism, increases labour productivity, and lowers household catastrophic health expenditure — all of which stimulate domestic consumption and economic activity.

Health Insurance as Financial Inclusion

Expanding health insurance coverage from 15.3% to 35% of the population — adding over 11 million enrollees — represents one of the most significant financial inclusion interventions in Tanzania's development agenda. Health insurance eliminates the risk of catastrophic out-of-pocket expenditure, a major driver of poverty. Households freed from health financial shocks increase consumption, savings, and investment in education, creating multiplier effects across the economy.

Medical Tourism & Health Export Economy

FYDP IV and Dira 2050 position Tanzania as a future top medical tourism destination. Currently, a significant share of Tanzania's high-income and middle-income population travels abroad for specialised medical care, generating substantial foreign exchange outflows. PPP-financed specialised care centres — targeting cardiac, oncology, neurology, and renal conditions — would retain this health expenditure domestically while attracting regional medical tourists, converting the health sector into a net foreign exchange earner.

Pharmaceutical Manufacturing as Industrial Policy

FYDP IV prioritises domestic pharmaceutical manufacturing as both a health security and industrial policy objective. Establishing local API and generic medicine production reduces import dependency, creates manufacturing employment, and builds industrial capacity aligned with the African Medicines Agency framework. PPP-financed pharmaceutical plants represent a convergence of health economy and industrial development objectives.